ArticleDigestive diseases and sciences2022

Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.

Giorgos Bamias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.